These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28440197)

  • 1. Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach.
    Milano W; Colletti C; Capasso A
    Endocr Metab Immune Disord Drug Targets; 2017; 17(1):38-55. PubMed ID: 28440197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
    Peuskens J; Pani L; Detraux J; De Hert M
    CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.
    De Hert M; Detraux J; Stubbs B
    Expert Opin Drug Saf; 2016 Jun; 15(6):809-23. PubMed ID: 26986209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics.
    Bonete Llácer JM; Martínez Hortelano A; Richart Albelda B
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):189-193. PubMed ID: 30848967
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.
    De Hert M; Peuskens J; Sabbe T; Mitchell AJ; Stubbs B; Neven P; Wildiers H; Detraux J
    Acta Psychiatr Scand; 2016 Jan; 133(1):5-22. PubMed ID: 26114737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of atypical antipsychotics on serum prolactin levels.
    Hamner M
    Ann Clin Psychiatry; 2002 Sep; 14(3):163-73. PubMed ID: 12585566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Ivanova SA; Osmanova DZ; Boiko AS; Pozhidaev IV; Freidin MB; Fedorenko OY; Semke AV; Bokhan NA; Kornetova EG; Rakhmazova LD; Wilffert B; Loonen AJ
    Schizophr Res; 2017 Apr; 182():110-114. PubMed ID: 27776952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.
    Halbreich U; Kinon BJ; Gilmore JA; Kahn LS
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():53-67. PubMed ID: 12504072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
    Tschoner A; Engl J; Rettenbacher MA; Kaser S; Ott HW; Fleischhacker WW; Patsch JR; Ebenbichler CF
    J Clin Psychiatry; 2009 Feb; 70(2):293-4. PubMed ID: 19265646
    [No Abstract]   [Full Text] [Related]  

  • 12. Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: A case series.
    Naono-Nagatomo K; Naono H; Abe H; Takeda R; Funahashi H; Uchimura D; Ishida Y
    Asian J Psychiatr; 2017 Feb; 25():36-41. PubMed ID: 28262171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia and Antipsychotic Therapy in Schizophrenic Patients with Hashimoto's Thyroiditis.
    Sobolevskaia PA; Churilov LP; Fedotkina TV; Stepochkina A; Dolina A; Gvozdetckii AN; Andreev BV; Shoenfeld Y
    Psychiatr Danub; 2021; 33(Suppl 4):1106-1112. PubMed ID: 35354176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
    Poyraz BC; Aksoy C; Balcioğlu I
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.
    Montgomery J; Winterbottom E; Jessani M; Kohegyi E; Fulmer J; Seamonds B; Josiassen RC
    J Clin Psychiatry; 2004 Nov; 65(11):1491-8. PubMed ID: 15554761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
    Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
    Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.
    Osmanova DZ; Freidin MB; Fedorenko OY; Pozhidaev IV; Boiko AS; Vyalova NM; Tiguntsev VV; Kornetova EG; Loonen AJM; Semke AV; Wilffert B; Bokhan NA; Ivanova SA
    BMC Med Genet; 2019 Apr; 20(Suppl 1):47. PubMed ID: 30967134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.